Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,425 EUR | +0,71% | -5,32% | -64,38% |
11/04 | Brusselse beurs opent aarzelend | AM |
07/04 | Brusselse beurs begint nieuw kwartaal terughoudend | AM |
Omzet 2023 | 712K 760K | Omzet 2024 * | 650K 694K | Marktkapitalisatie | 40,25 mln. 42,95 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -32 mln. -34,15 mln. | Nettowinst (verlies) 2024 * | -20 mln. -21,34 mln. | EV/omzet 2023 | 159 x |
Nettoschuld 2023 * | 11,85 mln. 12,65 mln. | Nettoschuld 2024 * | 47,5 mln. 50,69 mln. | EV/omzet 2024 * | 135 x |
K/w-verhouding 2023 |
-3,28
x | K/w-verhouding 2024 * |
-2,42
x | Werknemers | 70 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 76,56% |
Recentste transcriptie over Sequana Medical N.V.
1 dag | +0,71% | ||
1 week | -4,68% | ||
Lopende maand | -5,32% | ||
1 maand | -34,33% | ||
3 maanden | -59,29% | ||
6 maanden | -39,62% | ||
Lopend jaar | -64,38% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 01-01-16 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 19-07-22 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 08-11-18 |
Ids van der Weij
BRD | Director/Board Member | - | 10/11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 1,425 | +0,71% | 50 039 |
16-04-24 | 1,415 | -5,35% | 27 009 |
15-04-24 | 1,495 | -0,33% | 76 208 |
12-04-24 | 1,5 | 0,00% | 79 407 |
11-04-24 | 1,5 | -0,33% | 35 315 |
Real Time Euronext Bruxelles, 17 april 2024 om 17:29 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-64,38% | 42,47 mln. | |
-1,78% | 41,71 mld. | |
+47,70% | 41,56 mld. | |
+4,01% | 39,74 mld. | |
-15,14% | 25,61 mld. | |
+3,16% | 24,26 mld. | |
-24,08% | 18,55 mld. | |
-2,67% | 11,93 mld. | |
+24,76% | 11,93 mld. | |
+7,01% | 10,91 mld. |